| 2017年12月4日 |
Ito, M., Hayashi, K., Minamisawa, T., Homma, S., Koido, S. and Shiba, K. Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells.
PLoS One, 12, e0188934 (2017) |
| 2017年11月10日 |
Yoshida, M., Hibino, K., Yamamoto, S., Matsumura, S., Yajima, Y. and Shiba, K. Preferential capture of EpCAM-expressing extracellular vesicles on solid surfaces coated with an aptamer-conjugated zwitterionic polymer.
Biotechnol Bioeng, in press (2017) |
| 2017年10月23日 |
Tanaka, M., Yoshimoto, T. and Nakamura, T. A double-edged sword: the world according to Capicua in cancer.
Cancer Sci., in press (2017) |
| 2017年9月26日 |
Osako, T., Iwase, T., Ushijima, M., Yonekura, R., Ohno, S. and Akiyama, F. A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients.
Br. J. Cancer., in press (2017) |
| 2017年8月29日 |
Takemoto, A., Miyata, K. and Fujita, N. Platelet-activating factor podoplanin: from discovery to drug development.
Cancer and metastasis reviews, 36, 225-234 (2017) |
| 2017年8月22日 |
Katayama, R. Therapeutic strategies and mechanisms of drug resistance in Anaplastic Lymphoma Kinase (ALK)-rearranged lung cancer.
Pharmacol. Ther., 117, 1-8 (2017) |
| 2017年7月28日 |
Fuse, J. M., Okada, K., Oh-hara, T., Ogura, H., Fujita, N. and Katayama, R. Mechanisms of resistance to NTRK inhibitors and therapeutic strategies in NTRK1-rearranged cancers.
Mol. Cancer Ther., 16, 2130-2143 (2017) |
| 2017年7月19日 |
Ogura, H., Nagatake-Kobayashi, Y., Adachi, J., Tomonaga, T., Fujita, N. and Katayama, R. TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.
Sci. Rep., 7, 5519 (2017) |
| 2017年7月13日 |
N. Tsuyama, R. Asaka, A. Dobashi, S. Baba, Y. Mishima, K. Ueda, M. Oguchi, H. Tsuji, K. hatake and K. Takeuchi. Epstein-Barr virus-negative extranodal “true” natural killer-cell lymphoma harbouring a KDM6A mutation.
Hematol. Oncol., in press (2017) |
| 2017年6月23日 |
Miyata, K., Takemoto, A., Okumura, S., Nishio, M. and Fujita, N. Podoplanin enhances lung cancer cell growth in vivo by inducing platelet
aggregation.
Sci. Rep., 7, 4059 (2017) |
| 2017年6月19日 |
Nakamura, T., Okabe, S., Yoshida, H., Iida, K., Ma, Y., Sasaki, S., Yamori, T., Shin-Ya, K., Nakano, I., Nagasawa, K. and Seimiya, H. Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.
Sci Rep, 7, 3605 (2017)
|
| 2017年6月7日 |
Takasugi, M., Okada, R., Takahashi, A., Chen, D. V., Watanabe, S. and Hara, E. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2.
Nat. Commun., doi:10.1038/ncomms15728 (2017) |
| 2017年5月25日 |
Mashima, T., Taneda, Y., Jang, M. K., Mizutani, A., Muramatsu, Y., Yoshida, H., Sato, A., Tanaka, N., Sugimoto, Y. and Seimiya, H. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Oncotarget, doi: 10.18632/oncotarget.18146 (2017) |
| 2017年5月25日 |
Migita, T., Ueda, A., Ohishi, T., Hatano, M., Seimiya, H., Horiguchi, S., Koga, F. and Shibasaki, F. Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.
Lab. Invest., 97, 567-576 (2017) |
| 2017年5月19日 |
N. Tsuyama, S. Sakata, S. Baba, Y. Mishima, N. Nishimura, K. Ueda, M. Yokoyama, Y. Terui, K. Hatake, M. Kitagawa, N. Ishizuka, N. Tomita and K. Takeuchi. BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.
Blood, in press (2017) |
| 2017年5月17日 |
Takahashi, A., Okada, R., Nagao, K., Kawamata, Y., Hanyu, A., Yoshimoto, S., Takasugi, M., Watanabe, S., Kanemaki, M., Obuse, C. and Hara, E. Exosomes maintain cellular homeostasis by excreting harmful DNA from cells.
Nat. Commun., 8, 15287 (2017) |
| 2017年4月21日 |
Yoshimoto, T., Motoi, N., Yamamoto, N., Nagano, H., Ushijima, M., Matsuura, M., Okumura, S., Yamaguchi, T., Fukayama, M. and Ishikawa, Y. Pulmonary carcinoids and low-grade gastrointestinal neuroendocrine tumors show common nicroRNA expression profiles, different from adenocarcinomas and small cell carcinomas.
Neuroendocrinology, in press (2017) |
| 2017年4月14日 |
T. Yoshimoto, M. Tanaka, M. Homme, Y. Yamazaki, Y. Takazawa, C. R. Antonescu and T. Nakamura. CIC-DUX4 induces small round cell sarcomas distinct from Ewing sarcoma.
Cancer research, in press, (2017) |
| 2017年3月27日 |
Tsuyama, N., Ennishi, D., Yokoyama, M., Baba, S., Asaka, R., Mishima, Y., Terui, Y., Hatake, K. and Takeuchi, K. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Oncotarget, 16532 (2017) |
| 2017年3月17日 |
Tamura, T., Kiura, K., Seto, T., Nakagawa, K., Maemondo, M., Inoue, A., Hida, T., Yoshioka, H., Harada, M., Ohe, Y., Nogami, N., Murakami, H., Kuriki, H., Shimada, T., Tanaka, T., Takeuchi, K. and Nishio, M. Three-year follow-up of an alectinib phase I/II study in ALK-positive non-small-cell lung cancer: AF-001JP.
J Clin Oncol, JCO2016705749 (2017) |
| 2017年3月16日 |
Yoshimura, K., Inui, N., Karayama, M., Inoue, Y., Enomoto, N., Fujisawa, T., Nakamura, Y., Takeuchi, K., Sugimura, H. and Suda, T. Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy.
Respir. Med. Case Rep., 20, 160-163 (2017) |
| 2017年3月14日 |
Uchibori, K., Inase, N., Araki, M., Kamada, M., Sato, S., Okuno, Y., Fujita, N. and Katayama, R. Brigatinib combined with anti-EGFR antibody overcomes Osimertinib resistance in EGFR-mutated non-small-cell lung cancer.
Nat. Commun., 8, 14768 (2017) |
| 2017年2月24日 |
Inamura, K., Yokouchi, Y., Kobayashi, M., Ninomiya, H., Sakakibara, R., Subat, S., Nagano, H., Nomura, K., Okumura, S., Sibutani, T. and Ishikawa, Y. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Oncotarget, in press (2017) |
| 2017年2月20日 |
S. Takeuchi, K. Fukuda, T. Yamada, S. Arai, S. Takagi, A. Ishii, S. Ochiai, S. Iwakiri, K. Itoi, H. Uehara, H. Nishihara, N. Fujita and S. Yano. Podoplanin promotes progression of malignant
pleural mesothelioma by regulating motility and focus formation.
Cancer Science, in press (2017) |
| 2017年2月17日 |
T. Ohishi, H. Yoshida, M. Katori, T. Migita, Y. Muramatsu, M. Miyake, Y. Ishikawa, A. Saiura, S. Iemura, T. Natsume and H. Seimiya. Tankyrase-binding protein TNKS1BP1 regulates actin cytoskeleton rearrangement and cancer cell invasion.
Cancer Research, in press (2017) |
| 2017年2月10日 |
Takemoto, A., Okitaka, M., Takagi, S., Takami, M., Sato, S., Nishio, M., Okumura, S. and Fujita, N. A critical role of platelet TGF-β release in podoplanin-mediated tumour
invasion and metastasis.
Sci. Rep., 7, 42186 (2017) |
| 2017年2月10日 |
Tanaka, N., Mashima, T., Mizutani, A., Sato, A., Aoyama, A., Gong, B., Yoshida, H., Muramatsu, Y., Nakata, K., Matsuura, M., Katayama, R., Nagayama, S., Fujita, N., Sugimoto, Y. and Seimiya, H. APC mutations as a potential biomarker for sensitivity to tankyrase inhibitors in colorectal cancer.
Mol. Cancer Ther., in press (2017) |
| 2017年2月8日 |
Katayama, R. Therapeutic strategies and mechanisms of drug resistance in Anaplastic Lymphoma Kinase (ALK)-rearranged lung cancer.
Pharmacology &Therapeutics, in press (2017) |
